MedTech

6 articles
The Motley FoolThe Motley Fool··Adria Cimino

Three Healthcare Giants Positioned for Long-Term Wealth Creation

Healthcare stocks $JNJ, $VRTX, and $UNH offer compelling long-term wealth-building opportunities through strong fundamentals, dividend history, and operational improvements.
JNJUNHVRTXCRSPbiotechpharmaceuticals
GlobeNewswire Inc.GlobeNewswire Inc.··Manufacturing By Informa

MD&M South 2026 Bolsters Industry Credentials with Strategic Partnership Push

MD&M South 2026 announces partnerships with industry organizations to enhance its Charlotte medical device manufacturing event through networking, sustainability, and innovation initiatives.
SWKSWPbiotechsustainability
BenzingaBenzinga··Prnewswire

Getinge Reports SEK 35B Revenue, Navigates Tariffs and Currency Headwinds

Getinge reported SEK 35B revenue with organic growth across all segments, maintaining margins despite SEK 1B in tariff and currency headwinds. Dividend proposed at SEK 4.75 per share.
GNGBYregulatory compliancedividend
The Motley FoolThe Motley Fool··Jonathan Ponciano

Bridger's $7M Masimo Exit Proved Costly as $9.9B Acquisition Sparked 34% Rally

Bridger Management sold its $7M Masimo stake after 12% decline; weeks later, a $9.9B acquisition sparked 34% surge, highlighting investment timing risks.
MSMSpAMSpEMSpFMSpI+8acquisitionportfolio management
GlobeNewswire Inc.GlobeNewswire Inc.··Informa Markets Manufacturing

MD&M West Convenes 1,800+ Exhibitors for 41st Annual Medical Device Manufacturing Summit

MD&M West's 41st annual summit attracted 1,800+ exhibitors from 43 countries to discuss AI integration, manufacturing innovations, and workforce development challenges in medical device production.
CAJPYNINOYworkforce developmentmedical device manufacturing
The Motley FoolThe Motley Fool··Adria Cimino

Intuitive Surgical's Market Resilience Rooted in Surgical Automation Dominance

Intuitive Surgical dominates robotic surgery market with resilient recurring revenue from instruments and services, insulating it from economic downturns.
ISRGhealthcare stockscompetitive moat